<VariationArchive RecordType="classified" VariationID="468334" VariationName="NC_000007.14:g.(?_45038253)_(45076470_?)del" VariationType="Deletion" Accession="VCV000468334" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-15" DateCreated="2017-12-26" MostRecentSubmission="2017-12-26">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="456824" VariationID="468334">
      <GeneList>
        <Gene Symbol="CCM2" FullName="CCM2 scaffold protein" GeneID="83605" HGNC_ID="HGNC:21708" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="44999746" stop="45076470" display_start="44999746" display_stop="45076470" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="45039344" stop="45116068" display_start="45039344" display_stop="45116068" Strand="+" />
          </Location>
          <OMIM>607929</OMIM>
        </Gene>
        <Gene Symbol="LOC132090779" FullName="Neanderthal introgressed variant-containing enhancer experimental_99227" GeneID="132090779" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>7p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="45074405" stop="45074574" display_start="45074405" display_stop="45074574" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NC_000007.14:g.(?_45038253)_(45076470_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7p13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" innerStart="45038253" innerStop="45076470" display_start="45038253" display_stop="45076470" variantLength="38218" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" innerStart="45077852" innerStop="45116069" display_start="45077852" display_stop="45116069" variantLength="38218" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.(?_45038253)_(45076470_?)del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.(?_45038253)_(45076470_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.(?_45077852)_(45116069_?)del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.(?_45077852)_(45116069_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000007.14:g.(?_45038253)_(45076470_?)del AND Cerebral cavernous malformation 2" Accession="RCV000557086" Version="1">
        <ClassifiedConditionList TraitSetID="684">
          <ClassifiedCondition DB="MedGen" ID="C1864041">Cerebral cavernous malformation 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-09-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2016-09-29" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-12-26" MostRecentSubmission="2017-12-26">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="684" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="868" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cerebral cavernous malformations 2</ElementValue>
                <XRef ID="Cerebral+cavernous+malformations+2/7938" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cerebral cavernous malformation 2</ElementValue>
                <XRef ID="MONDO:0011304" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CCM2</ElementValue>
                <XRef Type="MIM" ID="603284" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cerebral cavernous malformations (CCMs) are vascular malformations in the brain and spinal cord comprising closely clustered, enlarged capillary channels (caverns) with a single layer of endothelium without mature vessel wall elements or normal intervening brain parenchyma. The diameter of CCMs ranges from a few millimeters to several centimeters. CCMs increase or decrease in size and increase in number over time. Hundreds of lesions may be identified, depending on the person's age and the quality and type of brain imaging used. Although CCMs have been reported in infants and children, the majority become evident between the second and fifth decades with findings such as seizures, focal neurologic deficits, nonspecific headaches, and cerebral hemorrhage. Up to 50% of individuals with FCCM remain symptom free throughout their lives. Cutaneous vascular lesions are found in 9% of those with familial cerebral cavernous malformations (FCCM; see Diagnosis/testing) and retinal vascular lesions in almost 5%.</Attribute>
                <XRef ID="NBK1293" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18313" />
                <XRef ID="18313" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301470</ID>
                <ID Source="BookShelf">NBK1293</ID>
              </Citation>
              <Citation Type="general" Abbrev="AHA/ASA, 2014">
                <ID Source="PubMed">25355838</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Cavernoma Alliance UK, 2012">
                <URL>https://www.guideline.gov/summaries/summary/49007</URL>
              </Citation>
              <XRef ID="221061" DB="Orphanet" />
              <XRef ID="C1864041" DB="MedGen" />
              <XRef ID="MONDO:0011304" DB="MONDO" />
              <XRef Type="MIM" ID="603284" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1237461" SubmissionDate="2017-10-05" DateLastUpdated="2017-12-26" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="874909|MedGen:C1864041" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000644922" DateUpdated="2017-12-26" DateCreated="2017-12-26" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-09-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment Type="public">This variant is a gross deletion of the genomic region encompassing exons 2-10 of the CCM2 gene, which encodes ~98% of the total protein. The boundaries of this event are unknown, as the deletion extends beyond the assayed region for this gene and therefore may include exon 1 of the CCM2 gene (resulting in complete gene deletion) and/or encompass additional genes. Loss-of-function variants in CCM2 are known to be pathogenic. A deletion of exons 2-10 that is mediated by Alu repeat sequences in intron 1 and the intragenic region downstream of exon 10 has been reported in several individuals with cerebral cavernous malformations (PMID: 17160895). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CCM2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.(?_45077852)_(45116069_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1864041" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB3109251</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1237461" TraitType="Disease" MappingType="XRef" MappingValue="C1864041" MappingRef="MedGen">
        <MedGen CUI="C1864041" Name="Cerebral cavernous malformation 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>